KOERS: MERCK
Medicijnen stimuleren winst van Merck
Belegger.nl - 23 Jul 09:40
Merck KGaA says Q2 operating profit rises 15 pct
Reuters - 23 Jul 08:20
Merck withholds forecasts after cholesterol study
Reuters - 22 Jul 06:00
Merck voorzichtig na falen cholesterolmiddel
Belegger.nl - 21 Jul 23:39
Nieuwe tegenslag Merck en Schering-Plough
Belegger.nl - 21 Jul 20:39
Merck, Schering delay earnings for Vytorin update
Reuters - 21 Jul 14:01
Merck says Vioxx claimants will soon get checks
Reuters - 17 Jul 17:00
Oncomethylome sluit licentie- en testovereenkomst met Merck
Belegger.nl - 10 Jun 11:00
OncoMethylome sluit overeenkomst met Merck
Belegger.nl - 10 Jun 09:20
Merck says wins appeal on first Vioxx case
Reuters - 29 May 17:00
Merck settles state Vioxx probes, to pay $58 million
Reuters - 20 May 19:40
Merck extends deadline for Vioxx settlement
Reuters - 2 May 06:00
Merck hit hard by cholesterol drug rejection
Reuters - 29 Apr 18:01
Merck voert winst op
Belegger.nl - 23 Apr 11:39
Costs help Merck and Novartis, hit Lilly
Reuters - 21 Apr 20:00
Winst Merck omhoog
Belegger.nl - 21 Apr 15:00
Merck profit rises on gains from deal
Reuters - 21 Apr 14:00
Researchers charge Merck misrepresented Vioxx data
Reuters - 15 Apr 22:41
Schering, Merck hit by cholesterol drug fallout
Reuters - 31 Mar 14:20
Group to test Merck AIDS drug in gel
Reuters - 11 Mar 17:00
Merck obesity drug falls short in trial: analyst
Reuters - 10 Mar 17:00
Bedrijfsresultaat farmaceut Merck omlaag
Belegger.nl - 18 Feb 09:40
Merck reaches settlement in Medicaid rebate probe
Reuters - 7 Feb 19:40
Merck posts loss on Vioxx charges
Reuters - 30 Jan 18:00
Merck posts loss on Vioxx charges
Reuters - 30 Jan 17:00
Merck posts loss on Vioxx charges, shares fall
Reuters - 30 Jan 16:40
Merck posts loss on Vioxx charges
Reuters - 30 Jan 15:00
Omstreden pijnstiller leidt tot verlies Merck
Belegger.nl - 30 Jan 14:40
Merck profit plunges on Vioxx charges
Reuters - 30 Jan 14:00
NY subpoenas Merck and Schering-Plough over Vytorin
Reuters - 27 Jan 06:00
FDA says reviewing Merck, Schering-Plough drug
Reuters - 25 Jan 21:20
Judge denies class in Fosamax cases against Merck
Reuters - 4 Jan 21:40
Merck in $700 million schizophrenia deal
Reuters - 3 Jan 11:00
Merck in $700 million schizophrenia deal
Reuters - 3 Jan 07:40
Merck in $700 million schizophrenia deal
Reuters - 3 Jan 07:20
Panel rejects Merck over-the-counter statin bid
Reuters - 14 Dec 06:00
Reviewer questions Merck over-counter drug bid
Reuters - 11 Dec 19:00
Reviewer questions Merck over-counter drug bid
Reuters - 11 Dec 18:40
Merck issues cautious 2008 forecast
Reuters - 4 Dec 18:40
Merck 2008 outlook range mostly below expectations
Reuters - 4 Dec 15:20
Merck sees higher 2008 earnings as new drugs shine
Reuters - 4 Dec 14:40
Merck sees higher 2008 earnings as new drugs shine
Reuters - 4 Dec 14:20
Merck sees higher 2008 earnings as new drugs shine
Reuters - 4 Dec 13:40
Addex signs deal with Merck & Co, shares rise
Reuters - 3 Dec 10:20
Addex, Merck & Co sign $170.5 mln Parkinson's deal
Reuters - 3 Dec 08:40
Merck agrees to pay $4.85 billion in Vioxx settlement
Reuters - 9 Nov 22:01
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 21:00
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 19:40
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 19:20
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 17:20
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 15:40
Merck agrees to pay $4.85 bln in Vioxx settlement
Reuters - 9 Nov 15:01
Merck bevestigt schikking USD 4,85 mrd voor Vioxx-claims
Eurobench - 9 Nov 15:00
Merck settles Vioxx claims for $4.85 billion
Reuters - 9 Nov 14:20
Merck set for Vioxx settlement: report
Reuters - 9 Nov 13:20
'Merck schikt voor USD 4,85 mrd Vioxx-claims'
Eurobench - 9 Nov 13:20
"Merck schikt klachten over Vioxx"
Belegger.nl - 9 Nov 13:20
Merck seen set for $4.85 billion Vioxx settlement:
Reuters - 9 Nov 11:00
Merck set for $4.85 billion Vioxx settlement: report
Reuters - 9 Nov 09:01
Merck shares seen rising on growth: Barron's
Reuters - 28 Oct 17:20
Merck maakt fors meer winst
Belegger.nl - 24 Oct 09:20
Merck quarterly profit rises
Reuters - 22 Oct 17:41
Merck maakt flink meer winst
Belegger.nl - 22 Oct 15:00
Merck & Co. verhoogt opnieuw winstverwachting
Eurobench - 22 Oct 14:40
Merck quarterly profit jumps
Reuters - 22 Oct 14:02
Crucell handhaaft prognose ondanks afhaken Merck
Belegger.nl - 25 Sep 15:40
Crucell herhaalt verwachtingen na wegvallen HIV-vaccin Merck
Eurobench - 25 Sep 15:00
Crucell verliest tot 6,75% door wegvallen HIV-vaccin Merck
Eurobench - 24 Sep 13:00
Crucell onderuit na mislukt HIV-onderzoek Merck
Belegger.nl - 24 Sep 10:40
Merck jumps on Erbitux lung cancer survival news
Reuters - 11 Sep 13:40
Crucell geeft Merck exclusief toegang tot vaccin-technologie
Eurobench - 10 Sep 09:20
Crucell verstrekt licentie aan Merck & Co
Belegger.nl - 10 Sep 09:00
Merck wins reversal of Vioxx class-action status
Reuters - 6 Sep 19:20
Merck wins reversal of Vioxx class-action status
Reuters - 6 Sep 19:00
Merck wins reversal of Vioxx class-action status
Reuters - 6 Sep 18:01
Merck says NJ court overturns Vioxx class action
Reuters - 6 Sep 17:40
Merck "good" cholesterol drug meets trial goals
Reuters - 2 Sep 16:40
Merck "good" cholesterol drug meets trial goals
Reuters - 2 Sep 13:00
Merck "good" cholesterol drug meets trial goals
Reuters - 2 Sep 09:00
Merck boekt stevig meer winst
Belegger.nl - 25 Jul 09:40
German Merck Q2 operating profit up 58 percent
Reuters - 25 Jul 08:20
Merck shares jump on strong profit, raised forecast
Reuters - 23 Jul 20:40
CORRECTED: Merck shares jump on strong profit, raised forecast
Reuters - 23 Jul 20:20
Wall Street: Merck & Co uitschieter binnen Dow Jones
Eurobench - 23 Jul 20:00
Merck shares jump on strong profit, raised forecast
Reuters - 23 Jul 19:40
Merck profit jumps, raises forecast
Reuters - 23 Jul 14:40
Futures rise on deals, profits; Merck gains
Reuters - 23 Jul 14:40
Merck & Co. verhoogt opnieuw winstverwachting
Eurobench - 23 Jul 14:40
Meer winst voor het Amerikaanse Merck
Belegger.nl - 23 Jul 14:40
Merck profit jumps, raises forecast
Reuters - 23 Jul 14:00
Federal judge throws out a Merck Vioxx victory
Reuters - 31 May 06:00
Merck verkoopt Merck Generics aan Mylan voor EUR 4,9 mrd
Eurobench - 14 May 09:40
Merck KGaA sells generics unit to Mylan for $6.6 bln
Reuters - 13 May 20:00
Merck KGaA sells generics unit to Mylan for $6.6 bln
Reuters - 13 May 18:40
Merck & Co. keen on small acquisitions: executive
Reuters - 13 May 18:00
Merck sells generics unit
Reuters - 13 May 16:20
Merck to sell generics unit to Mylan for $6.6 bln
Reuters - 13 May 12:00
Merck to sell generics to Mylan for $6.6 bln
Reuters - 13 May 11:20
Merck to sell generics to Mylan for $6.6 bln
Reuters - 13 May 11:00
Brazil sidesteps patent on Merck AIDS drug
Reuters - 4 May 21:20
Stijgers: Hoogste omzet:
Antonov0,369,09%
OCE6,954,20%
UNIBAIL R...144,493,61%
TomTom17,302,91%
Vedior15,631,96%
ING9496217
Fortis8610739
Royal Dut...6117596
Ahold5856501
KPN5518380
Dalers: Laagste omzet:
USG People10,19-12,83%
Qurius0,55-6,78%
Boskalis34,05-6,30%
Fugro42,27-5,65%
Randstad18,74-5,16%
Van Lanschot...5
Hunter Douglas...268
Telegraaf394
Tele Atlas2006
Macintosh2924
AEX401,16-1,04%
AMX551,26-2,39%
BEL3.114,11-0,98%
BSE 2014.777,01-1,11%
CAC 404.362,44-1,05%
DAX6.467,35-1,05%
Dow Jones11.583,44-0,16%
FTSE5.413,10-0,68%
HangSeng23.087,72-0,20%
Jakarta2.257,051,40%
KLSE1.141,590,19%
Nasdaq2.306,410,11%
Nikkei13.603,312,18%
S&P1.278,760,14%
Shanghai2.910,292,55%
Straits T2.977,91-0,04%
Taiwan7.368,080,80%
Thailand2.977,91-0,04%


Realtime AEX Grafiek
aex grafiek
Aegon8,28-0,05%
Ahold7,49-2,41%
Akzo nobel42,98-1,51%
Arcelor ...49,55-2,27%
ASML14,51-1,89%
Corio53,65-0,59%
Corporat...10,26-4,47%
DSM34,28-1,55%
Elsevier10,180,89%
Fortis10,130,00%
Hagemeyer4,82-0,21%
Heineken30,20-0,17%
ING22,02-0,36%
KPN10,801,50%
Philips22,20-0,69%
Randstad18,74-5,16%
Royal Dutch23,14-1,76%
SBM Offs...14,76-2,45%
Tele Atlas30,00-0,66%
TNT25,75-1,57%
TomTom17,302,91%
UNIBAIL ...144,493,61%
Unilever18,48-0,46%
Vedior15,631,96%
Wolters klu14,33-1,44%
Aalberts10,44-2,34%
AMG49,93-0,93%
Arcadis7,27-3,84%
ASMI18,750,59%
BAM groep10,94-1,17%
Binck7,19-2,04%
Boskalis34,05-6,30%
Crucell9,95-0,70%
CSM21,14-2,13%
Draka18,42-1,97%
Eurocomm...30,530,96%
Fugro42,27-5,65%
Imtech15,06-2,78%
Logicacmg1,440,00%
Nutreco40,54-0,90%
OCE6,954,20%
Ordina8,58-2,94%
SNS Reaal11,210,36%
USG People10,19-12,83%
Vastned ...0,000,00%
Vopak37,11-3,13%
Wavin5,52-1,78%
Wereldhave7,52-4,08%
Wessanen6,94-0,86%

Copyright 2007 © Dijksma.net - Algemene Voorwaarden - disclamer - Adverteren - Contact
laadtijd: 0.094381 sec.
Hosting - Techniek

View Dirk Dijksma's LinkedIn profileWie brengt u deze website? Dirk Dijksma's profile